Literature DB >> 24012508

Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.

Morris J Cohen1, Kimford J Meador, Nancy Browning, Ryan May, Gus A Baker, Jill Clayton-Smith, Laura A Kalayjian, Andres Kanner, Joyce D Liporace, Page B Pennell, Michael Privitera, David W Loring.   

Abstract

The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study is a prospective observational multicenter study in the USA and UK, which enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study aimed to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, and valproate). In this report, we examine fetal AED exposure effects on adaptive and emotional/behavioral functioning at 6years of age in 195 children (including three sets of twins) whose parent (in most cases, the mother) completed at least one of the rating scales. Adjusted mean scores for the four AED groups were in the low average to average range for parent ratings of adaptive functioning on the Adaptive Behavior Assessment System-Second Edition (ABAS-II) and for parent and teacher ratings of emotional/behavioral functioning on the Behavior Assessment System for Children (BASC). However, children whose mothers took valproate during pregnancy had significantly lower General Adaptive Composite scores than the lamotrigine and phenytoin groups. Further, a significant dose-related performance decline in parental ratings of adaptive functioning was seen for both valproate and phenytoin. Children whose mothers took valproate were also rated by their parents as exhibiting significantly more atypical behaviors and inattention than those in the lamotrigine and phenytoin groups. Based upon BASC parent and teacher ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy were at a significantly greater risk for a diagnosis of ADHD. The increased likelihood of difficulty with adaptive functioning and ADHD with fetal valproate exposure should be communicated to women with epilepsy who require antiepileptic medication. Finally, additional research is needed to confirm these findings in larger prospective study samples, examine potential risks associated with other AEDs, better define the risks to the neonate that are associated with AEDs for treatment of seizures, and understand the underlying mechanisms of adverse AED effects on the immature brain.
© 2013.

Entities:  

Keywords:  Antiepileptic drugs; Behavioral neurology; Child development; Epilepsy; Pregnancy; Valproate

Mesh:

Substances:

Year:  2013        PMID: 24012508      PMCID: PMC3902100          DOI: 10.1016/j.yebeh.2013.08.001

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  24 in total

1.  Effect of high doses of folic acid supplementation in early pregnancy on child neurodevelopment at 18 months of age: the mother-child cohort 'Rhea' study in Crete, Greece.

Authors:  Leda Chatzi; Eleni Papadopoulou; Katerina Koutra; Theano Roumeliotaki; Vaggelis Georgiou; Nikolaos Stratakis; Vassiliki Lebentakou; Mariana Karachaliou; Maria Vassilaki; Manolis Kogevinas
Journal:  Public Health Nutr       Date:  2012-02-08       Impact factor: 4.022

2.  Autism spectrum disorders following in utero exposure to antiepileptic drugs.

Authors:  R L Bromley; G Mawer; J Clayton-Smith; G A Baker
Journal:  Neurology       Date:  2008-12-02       Impact factor: 9.910

3.  Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Brain       Date:  2011-01-11       Impact factor: 13.501

4.  Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.

Authors:  K J Meador; G A Baker; N Browning; M J Cohen; R L Bromley; J Clayton-Smith; L A Kalayjian; A Kanner; J D Liporace; P B Pennell; M Privitera; D W Loring
Journal:  Neurology       Date:  2012-04-04       Impact factor: 9.910

5.  Sedative and anticonvulsant drugs suppress postnatal neurogenesis.

Authors:  Vanya G Stefovska; Ortrud Uckermann; Miroslaw Czuczwar; Martin Smitka; Piotr Czuczwar; Jacek Kis; Angela M Kaindl; Lechoslaw Turski; Waldemar A Turski; Chrysanthy Ikonomidou
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

6.  The behavioral consequences of exposure to antiepileptic drugs in utero.

Authors:  J Vinten; R L Bromley; J Taylor; N Adab; U Kini; G A Baker
Journal:  Epilepsy Behav       Date:  2008-12-02       Impact factor: 2.937

Review 7.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; K J Meador; P B Pennell; W A Hauser; G S Gronseth; J A French; S Wiebe; D Thurman; B S Koppel; P W Kaplan; J N Robinson; J Hopp; T Y Ting; B Gidal; C A Hovinga; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; D Hirtz; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

8.  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Jill Clayton-Smith; Deborah T Combs-Cantrell; Morris Cohen; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

Review 9.  Teratogenicity of antiepileptic medications.

Authors:  Benzi M Kluger; Kimford J Meador
Journal:  Semin Neurol       Date:  2008-07-24       Impact factor: 3.420

10.  Folic acid supplements in pregnancy and severe language delay in children.

Authors:  Christine Roth; Per Magnus; Synnve Schjølberg; Camilla Stoltenberg; Pål Surén; Ian W McKeague; George Davey Smith; Ted Reichborn-Kjennerud; Ezra Susser
Journal:  JAMA       Date:  2011-10-12       Impact factor: 56.272

View more
  35 in total

Review 1.  [Pharmacological treatment of women with epilepsy before and during pregnancy].

Authors:  B Müffelmann; C G Bien
Journal:  Nervenarzt       Date:  2016-10       Impact factor: 1.214

2.  Effects of periconceptional folate on cognition in children of women with epilepsy: NEAD study.

Authors:  Kimford J Meador; Page B Pennell; Ryan C May; Carrie A Brown; Gus Baker; Rebecca Bromley; David W Loring; Morris J Cohen
Journal:  Neurology       Date:  2019-12-23       Impact factor: 9.910

Review 3.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

Review 4.  Neurodevelopmental Effects of Antiepileptic Drugs.

Authors:  Marissa Kellogg; Kimford J Meador
Journal:  Neurochem Res       Date:  2017-04-19       Impact factor: 3.996

Review 5.  Developmental effects of antiepileptic drugs and the need for improved regulations.

Authors:  Kimford J Meador; David W Loring
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

6.  Comments on Motamedi G, Meador K. Epilepsy and cognition. Epilepsy & behavior 2003;4:S25-S28.

Authors:  Robyn M Busch
Journal:  Epilepsy Behav       Date:  2014-10-11       Impact factor: 2.937

7.  2014 Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across The Lifespan.

Authors:  Alica M Goldman; W Curt LaFrance; Tim Benke; Miya Asato; Dan Drane; Alison Pack; Tanvir Syed; Robert Doss; Samden Lhatoo; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

Review 8.  Turing Revisited: Decoding the microRNA Messages in Brain Extracellular Vesicles for Early Detection of Neurodevelopmental Disorders.

Authors:  Virginie Gillet; Darel John Hunting; Larissa Takser
Journal:  Curr Environ Health Rep       Date:  2016-09

Review 9.  Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk?

Authors:  David S Baldwin; Hugo J F Amaro
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

Review 10.  The Placental Barrier: the Gate and the Fate in Drug Distribution.

Authors:  Nino Tetro; Sonia Moushaev; Miriam Rubinchik-Stern; Sara Eyal
Journal:  Pharm Res       Date:  2018-02-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.